ALB and Bone marrow hypocellularity: Our analyses revealed statistically significant pharmacovigilance signals for several serious adverse events, including bone marrow failure, hypoplastic anemia, leukopenia, hepatic disorders and hepatitis, with particularly strong signals reported after ALB exposure.